Allogene Therapeutics, Inc. Other Current Liabilities
Allogene Therapeutics, Inc. (ALLO) had Other Current Liabilities of $2.40 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-03-12
- 2025-12-31: Other Liabilities, Current $2.40M.
- 2024-12-31: Other Liabilities, Current $1.07M.
- 2023-12-31: Other Liabilities, Current $1.81M.
- 2022-12-31: Other Liabilities, Current $2.12M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $2.40M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $1.07M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $1.81M 10-K · filed 2025-03-13 | |
| 2022-12-31 | $2.12M 10-K/A · filed 2024-03-14 | |
| 2021-12-31 | $1.75M 10-K/A · filed 2024-03-14 | $4.95M 10-K · filed 2022-02-23 |
| 2020-12-31 | $4.79M 10-K · filed 2022-02-23 | |
| 2019-12-31 | $3.02M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.97M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $2.25M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $1.40M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $612.00K 10-K · filed 2020-02-27 | |
| 2017-12-31 | $2.00K 10-K · filed 2019-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |